Decline in C-reactive protein after successful ablation of long-lasting persistent atrial fibrillation [4]

Journal of the American College of Cardiology

Volumn 47, Issue 6, 2006, Pages 1231-1233

  Rotter, Martin ^a   Jaïs, Pierre ^b   Vergnes, Marie Christine ^b   Nurden, Paquita ^b   Takahashi, Yoshihide ^b   Sanders, Prashanthan ^b   Rostock, Thomas ^b   Hocini, Mélèze ^b   Sacher, Fréderic ^b   Haïssaguerre, Michel ^b  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLASMA PROTEIN; VON WILLEBRAND FACTOR;

CARDIOVASCULAR RISK; CATHETER ABLATION; ELECTROCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INFLAMMATION; LETTER; PRIORITY JOURNAL; SINUS RHYTHM;

ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; CATHETER ABLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; REMISSION INDUCTION; TIME FACTORS;

EID: 33644915009     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.12.038     Document Type: Letter

References (11)

1. R.J. Aviles, D.O. Martin, C. Apperson-Hansen Inflammation as a risk factor for atrial fibrillation Circulation 108 2003 3006 3010
2. M.K. Chung, D.O. Martin, D. Sprecher C-reactive protein elevation in patients with atrial arrhythmias inflammatory mechanisms and persistence of atrial fibrillation Circulation 104 2001 2886 2891
3. D.S. Conway, L.A. Pearce, B.S. Chin Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation Circulation 107 2003 3141 3145
4. S.K. Thambidorai, K. Parakh, D.O. Martin Relation of C-reactive protein correlates with risk of thromboembolism in patients with atrial fibrillation Am J Cardiol 94 2004 805 807
5. M. Haissaguerre, P. Sanders, M. Hocini Changes in atrial fibrillation cycle length and inducibility during catheter ablation and their relation to outcome Circulation 109 2004 3007 3013
6. H.M. Tsao, M.H. Wu, B.H. Huan Morphologic remodeling of pulmonary veins and left atrium after catheter ablation of atrial fibrillation insight from long-term follow-up of three-dimensional magnetic resonance imaging J Cardiovasc Electrophysiol 16 2005 7 12
7. S.N. Psychari, T.S. Apostolou, L. Sinos Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation Am J Cardiol 95 2005 764 767
8. K. Kumagai, H. Nakashima, H. Urata Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation J Am Coll Cardiol 41 2003 2197 2204
9. Y. Nakano, S. Niida, K. Dote Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation J Am Coll Cardiol 43 2004 818 825
10. P.L. L'Allier, A. Ducharme, P.F. Keller Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation J Am Coll Cardiol 44 2004 159 164
11. F.L. Li-Saw-Hee, A.D. Blann, D. Gurney Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation Effects of cardioversion and return of left atrial function Eur Heart J 22 2001 1741 1747